<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.11613/BM.2014.018</dc:identifier><dc:language>eng</dc:language><dc:creator>Izquierdo Alvarez, Silvia</dc:creator><dc:creator>Barrio Ollero, Eva María</dc:creator><dc:creator>Llinares, FM</dc:creator><dc:creator>Lorente, F</dc:creator><dc:creator>Calvo Martin, M Teresa</dc:creator><dc:title>A deep vein thrombosis caused by 20209C&gt;T mutation in homozygosis of the prothrombin gene in a Caucasian patient</dc:title><dc:identifier>ART-2014-81191</dc:identifier><dc:description>Introduction: Additional nucleotide substitutions in the 3 ´-untranslated region of prothrombin gene could explain some thrombotic events and also adverse pregnancy outcomes. We describe the first case of a homozygous 20209C&gt;T mutation as the cause of deep vein thrombosis in a Spanish patient.
Case and methods: The 56-year-old male patient with a partial tear of the Achilles tendon developed calf (tibial) deep vein thrombosis after im- mobilization and was treated with an anticoagulant. To determine if the deep vein thrombosis was of genetic origin, a peripheral blood DNA sample was analysed for the presence of the three most frequent mutations associated with thrombotic events: factor V Leiden (1691G&gt;A), prothrombin (20210G&gt;A) and methylene tetrahydrofolate reductase (677C&gt;T). The presence or absence of the normal allele of prothrombin could not be deter- mined using the PTH-FV-MTHFR StripAssay (Vienna Lab).
Results: Comprehensive analysis showed that the patient had a variant interfering with the polymerase chain reaction product, we sequenced the entire prothrombin gene and found that the patient had a homozygous C&gt;T mutation at position 20209; this interfered with the polymerase chain reaction product, which needs a C at this position to be able to bind to the wild-type probe present in the test strip.
Conclusion: The homozygous 20209C&gt;T mutation and the presence of the mutation 677C&gt;T in heterozygosity explained the patient’s deep vein thrombosis because the combination of mutations would increase the risk of thrombosis. Suitable genetic counselling should be provided to the pa- tient and first-degree relatives as it important to detect prothrombin gene variants that could increase risk for thrombotic events.</dc:description><dc:date>2014</dc:date><dc:source>http://zaguan.unizar.es/record/32462</dc:source><dc:doi>10.11613/BM.2014.018</dc:doi><dc:identifier>http://zaguan.unizar.es/record/32462</dc:identifier><dc:identifier>oai:zaguan.unizar.es:32462</dc:identifier><dc:identifier.citation>Biochemia Medica 24, 1 (2014), 159-166</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>http://creativecommons.org/licenses/by-nc-nd/3.0/es/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>